
Bernd Kasper, MD, PhD, provides an overview of the phase 3 DeFi trial of nirogacestat for the treatment of patients with progressing desmoid tumors.

Your AI-Trained Oncology Knowledge Connection!

Bernd Kasper, MD, PhD, is a professor at Universitätsmedizin Mannheim, Mannheim.